SCHEMBL1796237

SCHEMBL1796237

COC(=O)c1cc(Cl)ccc1NC(=O)CN(C)CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
KDM4E B2RXH2 3/20 0.54
NPSR1 Q6W5P4 1/20 0.54
MAPT P10636 4/20 0.51
GAA P10253 2/20 0.51
NPC1 O15118 1/20 0.51
RECQL P46063 1/20 0.51
TP53 P04637 1/20 0.50
ALOX12 P18054 1/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
LMNA P02545 3/20 0.48
ATM Q13315 1/20 0.48
RXFP1 Q9HBX9 1/20 0.47
HTT P42858 1/20 0.47
POLB P06746 1/20 0.47
PKM P14618 1/20 0.47
NCOA1 Q15788 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1796902 0.89 TP53 (0.65) ALDH1A1KDM4ENPSR1MAPTGAA
SCHEMBL1798282 0.84 ALDH1A1 (0.60) ALDH1A1KDM4ENPSR1MAPTGAA
Hydrochloric Acid SCHEMBL11862407 0.82 SMN1; SMN2 (0.63) ALDH1A1KDM4EMAPTGAATP53
SCHEMBL417874 0.80 RXFP1 (0.54) ALDH1A1KDM4EGAANPC1SMN1; SMN2
SCHEMBL1015904 0.80 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTGAANPC1
SCHEMBL1015370 0.80 KDM4E (0.60) ALDH1A1KDM4EMAPTGAATP53
SCHEMBL6510154 0.79 KMT2A (0.63) ALDH1A1KDM4EGAASMN1; SMN2MEN1
SCHEMBL9674267 0.79 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTGAATP53
SCHEMBL30556513 0.79 RXFP1 (0.53) ALDH1A1KDM4EMAPTGAANPC1
SCHEMBL30044907 0.79 KMT2A (0.63) ALDH1A1KDM4EGAASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7951806-B2 Plasminogen activator inhibitor-1 inhibitor RENASCIENCE CO., LTD. (JP) 2011-05-31 US disclosed
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR RENASCIENCE CO., LTD. (JP) 2009-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124620-A1 PLASMINOGEN ACTIVATOR INHIBITOR-1 INHIBITOR SERPINE1, SERPINC1, SERPINB1 ALDH1A1 800/4885KDM4E 4309/4885NPSR1 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.